Tau pathology in a family with dementia and a P301L mutation in tau

Journal of Neuropathology and Experimental Neurology

Volumn 58, Issue 4, 1999, Pages 335-345

  Mirra, Suzanne S ^a   Murrell, Jill R ^b   Gearing, Marla ^c,f   Spillantini, Maria G ^e   Goedert, Michel ^d   Crowther, R Anthony ^d,f   Levey, Allan I ^c   Jones, Randi ^c   Green, Joanne ^c   Shoffner, John M ^d   Wainer, Bruce H ^c   Schmidt, Marie L ^g   Trojanowski, John Q ^g   Ghetti, Bernardino ^b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Corticobasal degeneration; Dementia; Frontotemporal dementia with parkinsonism; Mutation; Tau

Indexed keywords

TAU PROTEIN;

ADULT; ARTICLE; CASE REPORT; CHROMOSOME 17; FAMILIAL DISEASE; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NEUROPATHOLOGY; PEDIGREE; PRIORITY JOURNAL;

EID: 0032920233     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199904000-00004     Document Type: Article

References (62)

1. Brun A. Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology. Arch Gerontol Geriatr 1987;6:193-208
2. Neary D. Non Alzheimer's disease forms of cerebral atrophy. J Neurol Neurosurg Psych 1990;53:929-31
3. Neary D, Snowden JS, Northern B, Goulding P. Dementia of frontal lobe type. J Neurol Neurosurg Psych 1988;51:353-61
4. Miller BL, Cummings JL, Villanueva-Meyer J, et al. Frontal lobe degeneration: Clinical, neuropsychological, and SPECT characteristics. Neurology 1991;40:251-56
5. Brun A, Englund B, Gustafson L, et al. The Lund and Manchester Groups. Consensus statement. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psych 1994; 4:416-18
6. Jackson M, Lowe J. The new neuropathology of degenerative frontotemporal dementias. Acta Neuropathol 1996;91:127-34
7. Neumann MA, Cohn R. Progressive subcortical gliosis, a rare form of presenile dementia. Brain 1967;90:405-18
8. Morris JC, Cole M, Banker BQ, Wright D. Hereditary dysphasic dementia and the Pick-Alzheimer spectrum. Ann Neurol 1984;16: 455-66
9. Knopman DS, Mastri AR, Frey WH, Sung JH, Rustan T. Dementia lacking distinctive histologic features: A common non-Alzheimer degenerative dementia. Neurology 1990;40:251-56
10. Hulette CM, Crain BJ. Lobar atrophy without Pick bodies. Clin Neuropathol 1992;11:151-56
11. Lynch T, Sano M, Marder KS, et al. Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex. Neurology 1994;44:1878-84
12. Lendon CL, Lynch T, Norton J, et al. Hereditary dysphasic disinhibition dementia: A frontotemporal dementia linked to 17q21-22. Neurology 1998;50:1546-55
13. Wilhelmsen KC, Lynch T, Pavlov E, Higgins M, Nygaard TG. Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22. Am J Hum Genet 1994;55:1159-65
14. Bird TD, Wijsman EM, Nochlin D, et al. Chromosome 17 and hereditary dementia: Linkage studies in three non-Alzheimer families and kindreds with late-onset FAD. Neurology 1997;48:949-54
15. Reed LA, Schmidt ML, Wszolek ZK, et al. The neuropathology of a chromosome 17-linked autosomal dominant parkinsonism and dementia ("pallido-ponto-nigral degeneration"). J Neuropathol Exp Neurol 1998;57:588-601
16. Foster NL, Wilhelmsen K, Sima AAF, Jones MZ, D'Amato CJ, Gilman S, and Conference Participants. Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus statement. Ann Neurol 1997;41:706-15
17. Spillantini MG, Goedert M, Crowther RA, Murrell JR, Farlow MR, Ghetti B. Familial multiple system tauopathy with presenile dementia: A disease with abundant neuronal and glial tau filaments. Proc Natl Acad Sci USA 1997;94:4113-18
18. Wilhelmsen KC. Frontotemporal dementia is on the MAP τ. Ann Neurol 1997;41:139-40
19. Murrell J, Koller D, Foroud T, et al. Familial multiple system tauopathy with presenile dementia localized to chromosome 17. Am J Hum Gen 1997;61:1131-38
20. Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA. Multiple isoforms of human microtubule-associated protein tau: Sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 1989;3:519-26
21. Goedert M, Spillantini MG, Potier MC, Ulrich J, Crowther RA. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: Differential expression of tau mRNAs in human brain. EMBO J 1989;8:393-99
22. Andreadis A, Brown WM, Kosik KS. Structure and novel exons of the human tau gene. Biochemistry 1992;31:10626-33
23. Poorkaj P, Bird TD, Wijsman E, et al. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 1998;43: 815-25
24. Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 5′ -splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998;393:702-5
25. Spillantini MG, Murrell JR, Goedert M, Farlow MJ, Klug A, Ghetti B. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci USA 1998;95:7737-41
26. Clark LN, Poorkaj P, Wszolek Z, et al. Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. Proc Natl Acad Sci USA 1998;95:13103-7
27. Dumanchin C, Camuzat A, Campion D, et al. Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism. Hum Mol Genet 1998;7:1825-29
28. Heutink P, Stevens M, Rizzu P, et al. Hereditary frontotemporal dementia is linked to chromosome 17q21-22: A genetic and clinicopathological study of three Dutch families. Ann Neurol 1997;41: 150-59
29. Spillantini MG, Crowther RA, Kamphorst W, Heutink P, van Swieten JC. Tau pathology in two Dutch families with mutations in the microtubule-binding region of tau. Am J Pathol 1998;153:1359-53
30. Wolozin BL, Pruchnicki A, Dickson DW, Davies P. A neuronal antigen in the brains of Alzheimer patients. Science 1986;232:648-51
31. Goedert M, Spillantini MG, Jakes R. Localization of the Alz-50 epitope in recombinant human microtubule-associated protein tau. Neurosci Lett 1991;126:149-54
32. Goedert M, Spillantini MG, Cairns NJ, Crowther RA, et al. Tau proteins of Alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms. Neuron 1992;8:159-68
33. 202 in Alzheimer's disease recapitulates phosphorylation during development. Proc Natl Acad Sci USA 1993;90:5066-70
34. Mercken M, Vandermeeren M, Luebke U, et al. Monoclonal antibodies with selective specificity for Alzheimer tau are directed against phosphatase-sensitive epitopes. Acta Neuropathol 1992;84: 265-72
35. Goedert M, Jakes R, Vanmechelen E. Monoclonal antibody AT8 recognizes tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett 1995;189:167-70
36. Hoffmann R, Lee VM-Y, Leight S, Varga I, Otvos L. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites. Biochemistry 1997;36:8114-24
37. Greenberg SG, Davies P, Schein JD, Binder LI. Hydrofluoric acid-treated τPHF proteins display the same biochemical properties as normal τ. J Biol Chem 1992;267:564-69
38. Lang E, Szendrei GI, Lee VM-Y, Otvos L. Immunological and conformational characterization of a phosphorylated immunodominant epitope on the paired helical filaments found in Alzheimer's disease. Biochem Biophys Res Commun 1992;187:783-90
39. 396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 1993;10:1089-99
40. Matsuo ES, Shin R-W, Billingsley ML, et al. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron 1994;13: 989-1002
41. Hasegawa M, Jakes R, Crowther RA, Lee VM-Y, Ihara Y, Goedert M. Characterization of mAb AP422, a novel phosphorylation dependent monoclonal antibody against tau protein. FEBS Lett 1996; 384:25-30
42. Schmidt ML, Lee V M-Y, Trojanowski JQ. Comparative epitope analysis of neuronal cytoskeletal proteins in Alzheimer's disease senile plaque neurites and neuropil threads. Lab Invest 1991;64: 352-57
43. Madisen L, Hoar DI, Holroyd CD, Crisp M, Hodes ME. DNA banking: The effects of storage of blood and isolated DNA on the integrity of DNA. Am J Med Genet 1987;27:379-90
44. Nichols WC, Gregg RE, Brewer HB, Benson MD. A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy. Genomics 1990;8:318-23
45. Goedert M, Jakes R. Expression of separate isoforms of human tau: correlation with the tau pattern in brains and effects on tubulin polymerization. EMBO J 1990;9:4225-30
46. Spillantini MG, Bird TD, Ghetti B. Frontotemporal dementia and parkinsonism linked to chromosome 17: A new group of tauopathies. Brain Path 1998;8:387-402
47. Goedert M, Jakes R, Spillantini MG, Hasegawa M, Smith MJ, Crowther RA. Sulphated glycosaminoglycans induce assembly of microtubule-associated protein tau into Alzheimer-like filaments. Nature 1996;383:550-53
48. Sumi SM, Bird TD, Nochlin D, Raskind MA. Familial presenile dementia with psychosis associated with cortical neurofibrillary tangles and degeneration of the amygdala. Neurology 1992;42:120-27
49. Spillantini MG, Crowther RA, Goedert M. Comparison of the neurofibrillary pathology in Alzheimer's disease and familial presenile dementia with tangles. Acta Neuropathol 1996;92:42-48
50. Reed LA, Grabowski TJ, Schmidt ML, et al. Autosomal dominant dementia with widespread neurofibrillary tangles. Ann Neurol 1997;42:564-72
51. Sima AF, Defendini R, Keohane C, et al. The neuropathology of chromosome 17-linked dementia. Ann Neurol 1996;39:734-43
52. Rey GJ, Tomer R, Levin BE, Sanchez-Ramos J, Bowen B, Bruce JH. Psychiatric symptoms, atypical dementia, and left visual field inattention in corticobasal ganglionic degeneration. Movement Disorders 1995;10:106-10
53. Mirra SS, Schneider JA, Gearing M. Neuropathology of movement disorders: An overview. In: Watts RL, Koller WC, eds. Movement disorders: Neurologic principles and practice. New York: McGraw Hill, 1997:125-34
54. Schneider JA, Watts RL, Gearing M, Brewer RP, Mirra SS. Corticobasal degeneration: Neuropathological and clinical heterogeneity. Neurology 1997;48:959-69
55. Feany MB, Dickson DW. Neurodegenerative disorders with extensive tau pathology: A comparative study and review. Ann Neurol 1996;40:139-48
56. Probst A, Tolnay M, Langui D, Goedert M, Spillantini MG. Pick's disease: Hyperphosphorylated tau protein segregates to the somatoaxonal compartment. Acta Neuropathol 1996;92:588-96
57. Gearing M, Olson D, Watts R, Mirra SS. Progressive supranuclear palsy: Neuropathologic and clinical heterogeneity. Neurology 1994; 44:1015-24
58. Flament S, Delacourte A, Verny M, Hauw JJ, Javoy-Agid F. Abnormal tau proteins in progressive supranuclear palsy: Similarities and differences with the neurofibrillary degeneration of the Alzheimer type. Acta Neuropathol 1991;81:591-96
59. Delacourte A, Robitaille Y, Sergeant N, et al. Specific tau protein variants characterize Pick's disease. J Neuropathol Exp Neurol 1996;55:159-68
60. Feany MB, Ksiezak-Reding H, Liu W-K, et al. Epitope expression and hyperphosphorylation of tau protein in corticobasal degeneration: Differentiation from progressive supranuclear palsy. Acta Neuropathol 1995;90:37-43
61. Ksiezak-Reding H, Morgan K, Mattiace LA, et al. Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration. Am J Pathol 1994;145:1-13
62. Buée-Scherrer V, Hof PR, Buée L, et al. Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick's disease. Acta Neuropathol 1996;91:351-59